Compounds > carbidopa

carbidopa and ascorbic acid

carbidopa has been researched along with ascorbic acid in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (18.18)	18.7374
1990's	2 (18.18)	18.2507
2000's	1 (9.09)	29.6817
2010's	5 (45.45)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
David, JC	1
Meadows, GG; Pierson, HF	1
López Lozano, JJ; Moreno Cano, R	1
Buhrfiend, C; Carvey, PM; Goetz, CG; Lipton, JW; Pappert, EJ; Stebbins, GT	1
Canals, S; Casarejos, MJ; de Bernardo, S; Handler, A; Mena, MA; Rodríguez-Martín, E	1
Ehm, G; Jeon, B; Kim, A; Kim, HJ; Kim, YE; Lee, WW; Yang, HJ; Yun, JY	1
Dhanalakshmi, N; Karthikeyan, V; Priya, T; Thinakaran, N	1
Kubo, M; Miyaue, N; Nagai, M	1

Reviews

1 review(s) available for carbidopa and ascorbic acid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

10 other study(ies) available for carbidopa and ascorbic acid

Article	Year
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Lethality of tyrosine in mice: its potentiation by decarboxylase inhibitors and reversal byascorbic acid. Naunyn-Schmiedeberg's archives of pharmacology, 1976, Volume: 293, Issue:1 Topics: Animals; Ascorbic Acid; Benserazide; Brocresine; Carbidopa; Drug Synergism; Intestinal Absorption; Kidney; Lethal Dose 50; Liver; Male; Mice; Phenylpyruvic Acids; Tyrosine; Tyrosine Decarboxylase	1976
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma. Cancer research, 1983, Volume: 43, Issue:5 Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine	1983
[Preparation of a levodopa/carbidopa solution in ascorbic acid (citridopa) and chromatographic and electrochemical assessment of its stability over 24 hours]. Neurologia (Barcelona, Spain), 1995, Volume: 10, Issue:4 Topics: Ascorbic Acid; Carbidopa; Chromatography, High Pressure Liquid; Drug Stability; Humans; Levodopa; Solutions; Time Factors	1995
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1 Topics: Antiparkinson Agents; Ascorbic Acid; Carbidopa; Drug Combinations; Drug Stability; Drug Storage; Humans; Levodopa; Light; Parkinson Disease; Temperature; Time Factors	1996
L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells. Journal of neurochemistry, 2001, Volume: 78, Issue:3 Topics: Antioxidants; Apoptosis; Ascorbic Acid; bcl-X Protein; Buthionine Sulfoximine; Carbidopa; Cell Differentiation; Culture Media, Conditioned; Culture Media, Serum-Free; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Neuroglia; Neurons; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase	2001
Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications. Journal of the neurological sciences, 2017, Jun-15, Volume: 377 Topics: Aged; Antiparkinson Agents; Ascorbic Acid; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Kaplan-Meier Estimate; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome	2017
3D cloves bud like Gd doped ZnO strewn rGO hybrid for highly selective determination of l-dopa in the presence of carbidopa and ascorbic acid. Journal of pharmaceutical and biomedical analysis, 2019, Sep-10, Volume: 174 Topics: Ascorbic Acid; Carbidopa; Equipment Design; Graphite; Humans; Hydrogen-Ion Concentration; Levodopa; Limit of Detection; Mucuna; Nanocomposites; Nanoparticles; Reproducibility of Results; Seeds; Urinalysis; X-Ray Diffraction; Zinc Oxide	2019
Ascorbic acid can alleviate the degradation of levodopa and carbidopa induced by magnesium oxide. Brain and behavior, 2022, Volume: 12, Issue:7 Topics: Antiparkinson Agents; Ascorbic Acid; Carbidopa; Humans; Levodopa; Magnesium Oxide; Parkinson Disease	2022